We used flow cytometry to validate the increased CD11b+Gr1+ cells in the lungs with time after 4T1 tumor implant (Fig. 1b, c) and also found an increased proportion and total number of CD11b+Gr1+ cells in the spleens of 4T1 tumor-bearing mice. The gene discussed is ITGAM; the disease is neoplasm.